Brain size may depend upon how neural cells are cleavedJuly 15, 2005Howard Hughes Medical Institute researchers have discovered a novel way in which the brain size of developing mammals may be regulated. They have identified a signaling pathway that controls the orientation in which dividing neural progenitor cells are cleaved during development. The way these cells are sliced during development is critical because at later stages of neurogenesis, vertical cleavage gives rise to two mature neurons that are incapable of further division, while horizontal cleavage yields one neuron and one progenitor cell that can continue to support brain growth. The researchers speculate that this type of regulatory decision point may play a powerful role in determining the ultimate size of the mammalian brain. Inherited disorders that cause the brain to develop too small or too large may also influence this developmental pathway.
Howard Hughes Medical Institute investigator Li-Huei Tsai and postdoctoral fellow Kamon Sanada, both at Harvard Medical School, published their findings in the July 15, 2005, issue of the journal Cell. The researchers drew on studies by other researchers that showed that the orientation of cleavage planes in dividing neural progenitor cells in the neocortex determines the fate of the resulting daughter cells. However, nothing was known about the molecular signaling mechanism that regulates the decision to cleave one way or another, said Tsai. Studies in fruit flies and roundworms had hinted that major regulatory molecules called heterotrimeric G proteins play a role in orienting the mitotic spindles that govern the orientation of cell cleavage during cell division, or mitosis. "Based on that knowledge, we knew that heterotrimeric G proteins were very good candidates as regulators of the plane of cell division in neural precursors," said Tsai. "And this is a very important question, because how these cells divide ultimately determines the final number of cells that will be generated during brain development," she said. Using the embryonic mouse brain as a model, Sanada and Tsai sought to determine whether G proteins play a role in the developing mammalian brain. In their initial experiments, they impaired the function of the Gβγ subunits of heterotrimeric G proteins, in the developing mouse brain. They saw a dramatic interference with orientation of cell cleavage to overproduce "postmitotic" neurons - cells that could no longer divide - at the expense of progenitor cells, which could still divide. "This observation led us to want to further test whether impairment of Gβγ has any consequences for cell fate in division, because it has been speculated that the different division planes dictate the ultimate cell fate adoption of daughter cells," said Tsai. To determine definitively whether impairment of Gβγ had a direct effect on cell fate, the researchers impaired Gβγ signaling in the mouse brains in utero, then isolated the progenitor cells to study the effects in vitro. Those studies revealed that impairing Gβγ did result in overproduction of neurons as a result of both daughter cells adopting the neuronal fate. Thus, the researchers concluded that Gβγ does control the orientation of cleavage and the identity of the daughter cells - whether they will become neurons or progenitor cells. Sanada and Tsai also sought to determine how Gβγ is regulated. Studies on asymmetric cell division in fruit flies and roundworms had implicated a particular class of proteins - known as AGS3 and mPins in mammals - as upstream regulators of G proteins. The researchers' analyses showed that AGS3 is, indeed, expressed in progenitor cells. And when they "silenced" AGS3 expression in embryonic mouse brains, the resulting abnormalities mimicked those produced when Gβγ signaling was disrupted. Now that the role of Gβγ in neural cell proliferation has been discovered, said Tsai, further studies will try to pinpoint how its signaling determines the orientation of spindles during mitosis, and thus the orientation of cell cleavage. "While this is basic research, we do know that this mechanism is very important in determining the ultimate size of the brain," said Tsai. "And, there are humans born with too few neurons, called microcephaly, or too many neurons, called macrocephaly. I would speculate that many of these cases are the outcome of some sort of impairment in the regulation of cell division, perhaps in the plane of division," said Tsai. "And with the possibility that neural stem cells may find therapeutic use, the role of G protein signaling in the differentiation of such progenitor cells is going to be a very exciting area to explore," she said. Howard Hughes Medical Institute | ||||||||||
|
Related Neural Progenitor Cells Current Events and Neural Progenitor Cells News Articles New molecular insight into vertebrate brain development In the December 1st issue of G&D, Dr. Fred H. Gage (The Salk Institute for Biological Studies) and colleagues reveal a role for the Hippo signaling pathway in the regulation of vertebrate neural development, identifying new factors - and potential therapeutic targets - that may be involved in congenital brain size disorders and neurological tumor formation. Sensitivity to antidepressants linked with TrkB-mediated neural proliferation Scientists have unveiled a functional link between production of new neurons and the effectiveness of antidepressants (ADs) in an animal model. The study, published by Cell Press in the August 14 issue of the journal Neuron, provides exciting insight into a mechanism that might underlie a poor response to antidepressive medications for anxiety or depression. Nerve cells derived from stem cells and transplanted into mice may lead to improved brain treatments Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience. Not all embryonic stem cell lines are created equal When it comes to generating neurons, researchers have found that not all embryonic stem (ES) cell lines are equal. In comparing neurons generated from two NIH-approved embryonic stem cell lines, scientists have uncovered significant differences in the mature, functioning neurons generated from each line. Stem cell therapy shows promise for rescuing deteriorating vision For the millions of Americans whose vision is slowly ebbing due to degenerative diseases of the eye, the lowly neural progenitor cell may be riding to the rescue. 'Gateway' gene discovered for brain cancer Researchers have discovered that the same genetic regulator that triggers growth of stem cells during brain development also plays a central role in the development of the lethal brain cancer malignant glioma. Dopamine drug leads to new neurons and recovery of function in rat model of Parkinson's In preliminary results, researchers have shown that a drug which mimics the effects of the nerve-signaling chemical dopamine causes new neurons to develop in the part of the brain where cells are lost in Parkinson's disease (PD). Neurons find their place in the developing nervous system with the help of a sticky molecule The brain, that exquisite network of billions of communicating cells, starts to take form with the genesis of nerve cells. Most newborn nerve cells, also called neurons, must travel from their birthplace to the position they will occupy in the adult brain. Columbia University Medical Center researchers discover potential mechanism for tumor growth Researchers at Columbia University Medical Center have identified an inherent feature of stem and progenitor cells that may promote initiation and progression of cancerous tumors. Nature press release for 3 May issue [411042] BRAIN: LIFE FROM DEATH (pp42-43) Researchers have identified another alternative to fetal tissue as a source of viable human brain cells. In a Brief Communication, Fred Gage, of the Salk Institute, La Jolla, California, and colleagues describe their feat of culturing neural progenitor cells from the brains of cadavers. Gage and colleagues were able to extract viable cells from most of the 23 post-mortem brains they examined. The ages of the deceased ranged from a few weeks to adult, and functioning cells were obtained up to 20 hours after death. The possible medical applications of this work are still hazy, and, although ethically less fraught, these post-mortem cells are not as pow More Neural Progenitor Cells Current Events and Neural Progenitor Cells News Articles |
||||||||||
|
||||||||||
|
||||||||||